Skip to content
Evevident

MRFIT

Multiple risk factor intervention trial. Risk factor changes and mortality results

Overview

Multifactor risk counseling improved risk factors but did not significantly reduce CHD mortality overall.

Clinical takeaway

MRFIT is a prevention-history landmark showing how hard population risk-factor intervention trials are, even when individual risk factors clearly matter.

Key result

Coronary heart disease mortality was not significantly lower with the special intervention program.

Practice impact

Reinforced risk-factor prevention while highlighting limits of broad behavioral intervention trials.

Evidence

Study design

Randomized primary-prevention trial.

Enrollment

12,866

Follow-up

Mean about 7 years.

Geography

United States

Clinical question

Does an intensive multifactor risk-factor intervention reduce coronary heart disease mortality in high-risk middle-aged men?

Population

  • Middle-aged men at increased risk for coronary heart disease based on smoking, cholesterol, and blood pressure.

Intervention

Special intervention targeting smoking cessation, dietary cholesterol reduction, and stepped-care hypertension treatment.

Comparator

Usual care referral to community physicians.

Primary outcome

Coronary heart disease mortality.

The multifactor intervention did not significantly reduce coronary heart disease mortality overall.

Between-group comparison / p=not significant

Key results

  • Risk factors improved more in the special-intervention group.
  • Coronary heart disease mortality was not significantly reduced overall.
  • Interpretation was complicated by improving community care and subgroup signals.

Harms

  • No single drug toxicity signal defines the trial; intervention burden and unintended treatment effects were concerns.

Clinical Use

When to cite

  • When teaching prevention trial complexity and historical cardiovascular risk-factor management.

Practice impact

  • Important historical anchor for preventive cardiology and risk-factor modification.

Applicability

  • Population prevention and counseling discussions, especially when distinguishing risk-factor causality from trial implementation.

Limitations

  • Enrolled only men and predates modern statins, antihypertensives, and tobacco-control policy.
  • Community care contamination likely reduced contrast.

Common misinterpretations

  • Do not conclude that smoking, BP, and cholesterol do not matter; the trial tested an intervention package, not the biology of each risk factor.

Citation

Multiple risk factor intervention trial. Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group. JAMA. 1982;248(12):1465-1477.

DOI
Not listed